Chemical and Pharmaceutical Bulletin p. 2096 - 2099 (1997)
Update date:2022-08-06
Topics:
Takeuchi, Yasuo
Kitaomo, Masayuki
Chang, Ming-Rong
Shirasaka, Shota
Shimamura, Chinami
Okuno, Yumiko
Yamato, Masatoshi
Harayama, Takashi
Indolo[3,2-b]quinoline derivatives (1b-i) with a methyl group at each possible position have been synthesized. The 1-methyl (1b) and 9-methyl (1i) derivatives were inactive, but the 3-methyl (1d), 4-methyl (1e), and 6- methyl (1f) derivatives exhibited high treatment/control (T/C) value and cure rates against leukemia P388 in mice. These results indicated that modification of indolo[3,2-b]quinoline derivatives at 3, 4, and 6 positions may be useful approach for lead optimization.
View MoreJinan Hongfangde Pharmatech Co.,Ltd
Contact:86-531-88870908
Address:F Bldg. West Unit North Area of Univ. Tech. Garden Xinyu Rd. Jinan New & High Tech Industry Development Zone Shandong, China
Contact:+86-532-80762375
Address:No. 6, Hongkong Middle Road, Qingdao, China
Ji'nan Orgachem Pharmaceutical Co.,Ltd
Contact:+86-531-82687810
Address:Jinan
Jiangsu Zenji Pharmaceuticals LTD
Contact:+86-025-83172562; +1-224-888-1133(USA)
Address:No.5 Xinmofan Road
Shenzhen ZheYi Chemicals Co.,LTD(Shanghai Branch)
Contact:+86-21-54159691
Address:Room1002,Building No.2, Lane 98 Bixiu Road,Minhang District, Shanghai,China 201100
Doi:10.1016/j.tetlet.2011.04.036
(2011)Doi:10.1016/j.crci.2010.11.001
(2011)Doi:10.1002/adsc.201000927
(2011)Doi:10.1039/c1ob05571b
(2011)Doi:10.1039/c5cc06712j
(2016)Doi:10.1016/j.bbagen.2011.03.001
(2011)
